Manozna Karri
Assistant Professor
University of Arkansas for Medical Sciences
faculty
COM | Internal Med Hem-Onc
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Manozna Karri's research focuses on hematology-oncology, with recent publications examining inflammatory myofibroblastic tumors and the impact of minimal residual disease status on clinical outcomes in multiple myeloma. Karri also investigates the variable dependence of clinical outcomes on gene expression profiling subgroups in multiple myeloma. Other work includes case reports on rare medical conditions such as risperidone-induced hyperprolactinemia, and a review of inflammatory myofibroblastic tumors. Karri has also explored challenges related to patient compliance in telemedicine settings. Collaborative efforts include shared publications with Phillip Farmer, Hira Imad Cheema, Trilok Shrivastava, and Syed Mujtaba Ali Naqvi, all from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 1
- Publications: 5
- Citations: 3
Selected Publications
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics